市场快照
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| CAGR: | 5.6 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
市场概况
心脏监测设备用于监测和诊断各种心脏异常或疾病。心脏监测市场的驱动因素包括心血管疾病负担的增加、极易患冠心病的老龄化人口不断增长、心脏监测设备的技术发展，可最大限度地减少感染机会，以及设备效率的提高。吸烟是导致肺癌和心脏病的主要原因之一。根据世界卫生组织 (WHO) 的数据，吸烟在亚太地区每年导致约 100 万人死于心血管疾病。超过五分之一的心血管疾病，如心脏病发作和中风，是由吸烟引起的。心脏基金会指出，心血管疾病是澳大利亚的主要死亡原因，2017 年有 43,477 人死于心血管疾病。由于心脏疾病负担的增加以及通过早期诊断控制死亡率的需要，以及借助心脏监测设备治疗心血管疾病，心血管疾病的诊断率随着时间的推移而增加。其他因素，如技术进步和对家庭、护理点和远程监测心脏系统的需求，预计也将在预测期内推动市场。
Scope of the report
Continuous cardiac monitoring is an important tool in the clinical assessment of patients with a variety of conditions. It allows the detection of changes in heart rate and rhythm and is essential in the detection of life-threatening arrhythmia's.
| Device Type | |
| ECG Monitor | |
| Event Recorder | |
| Implantable Cardiac Loop Recorder | |
| Pacemaker | |
| Defibrillator | |
| Cardiac Resynchronization Therapy (CRT) Devices | |
| Smart Wearable | |
| Other Device Types |
| End User | |
| Hospitals and Clinics | |
| Home Care Settings | |
| Ambulatory Surgical Centers |
| Geography | ||||||||
|
主要市场趋势
心电监护仪细分市场预计将在预测年份显示出更好的增长
根据设备类型，市场分为心电监护仪、事件记录仪、植入式心脏循环记录仪、起搏器、除颤器、CRT 设备、智能可穿戴设备等。ECG 设备可用于持续监测患有 CVD 的患者，并在通常更容易治疗时发现问题，同时避免危及生命和昂贵的紧急入院。具有启用蓝牙传感器技术和移动应用程序技术的商业先进设备的开发预计将推动心电监护仪的普及。2018 年，Qardio, Inc. 获得了澳大利亚治疗用品管理局 (TGA) 对其革命性心电图监测器 QardioCore 的批准。此外，
To understand key trends, Download Sample Report
竞争格局
亚太心脏监测市场的主要参与者有雅培、Biotronik、波士顿科学公司、GE Healthcare、Hill-Rom Holdings, Inc.、Medtronic PLC、MicroPort Scientific、Schiller AG。
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Rising Burden of Cardiovascular Diseases
-
4.2.2 Demand for Home-based, Point of Care and Remote Patients Monitoring Cardiac Systems
-
4.2.3 Technological Advancements
-
-
4.3 Market Restraints
-
4.3.1 Risk of Infection Due to Implantable Monitoring Devices
-
4.3.2 Lack of Skilled Personnel
-
-
4.4 Porter's Five Forces Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 Device Type
-
5.1.1 ECG Monitor
-
5.1.2 Event Recorder
-
5.1.3 Implantable Cardiac Loop Recorder
-
5.1.4 Pacemaker
-
5.1.5 Defibrillator
-
5.1.6 Cardiac Resynchronization Therapy (CRT) Devices
-
5.1.7 Smart Wearable
-
5.1.8 Other Device Types
-
-
5.2 End User
-
5.2.1 Hospitals and Clinics
-
5.2.2 Home Care Settings
-
5.2.3 Ambulatory Surgical Centers
-
-
5.3 Geography
-
5.3.1 Asia-Pacific
-
5.3.1.1 China
-
5.3.1.2 Japan
-
5.3.1.3 India
-
5.3.1.4 Australia
-
5.3.1.5 South Korea
-
5.3.1.6 Rest of Asia-Pacific
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Abbott
-
6.1.2 Biotronik
-
6.1.3 Boston Scientific Corporation
-
6.1.4 GE Healthcare
-
6.1.5 Hill-Rom Holdings, Inc.
-
6.1.6 Medtronic PLC
-
6.1.7 MicroPort Scientific
-
6.1.8 Schiller AG
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Asia-Pacific Cardiac Monitoring Market market is studied from 2018 - 2026.
What is the growth rate of Asia-Pacific Cardiac Monitoring Market?
The Asia-Pacific Cardiac Monitoring Market is growing at a CAGR of 5.6% over the next 5 years.
Who are the key players in Asia-Pacific Cardiac Monitoring Market?
Abbott Laboratories, Biotronik, Boston Scientific Corporation, Medtronic PLC, MicroPort Scientific are the major companies operating in Asia-Pacific Cardiac Monitoring Market.
